EU number	Indication
EU/3/22/2730	Treatment of peripheral T-cell lymphoma
EU/3/22/2736	Treatment of ornithine transcarbamylase deficiency
EU/3/22/2735	Treatment of idiopathic pulmonary fibrosis
EU/3/22/2733	Treatment in haematopoietic stem cell transplantation
EU/3/22/2732	Treatment of acute lymphoblastic leukaemia
EU/3/22/2731	Treatment of small cell lung cancer
EU/3/22/2724	Treatment of myotonic disorders
EU/3/22/2723	Treatment of ovarian cancer